Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Weidinger

Showing results (81-90 of 274) with videos related to

Pageof 28
Sort By:
Dermatology and Therapy|March 15, 2025
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED StudyStephan Weidinger, Tobias Schadeck, Felix Jacobs, et al.
The Journal of Investigative Dermatology|December 29, 2024
Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic ResponseRashmi Tandon, Inken Harder, Dora Stölzl, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2014
Skin barrier in atopic dermatitisSanja Kezic, Natalija Novak, Ivone Jakasa, et al.
Skin Pharmacology and Physiology|September 6, 2025
Effects of a gel containing the defined microalgae extract Spiralin® on the skin microbiome and clinical activity in atopic dermatitis - a double-blind, intraindividual vehicle-controlled proof-of-concept studyKristian Reich, Natalie Trettel, Jeremias L K Reich, et al.
Acta Dermato-Venereologica|June 11, 2015
Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and OmalizumabAlexander Zink, Anna Gensbaur, Michael Zirbs, et al.
BMC Medical Genetics|January 31, 2012
Multi-locus stepwise regression: a haplotype-based algorithm for finding genetic associations applied to atopic dermatitisSven Knüppel, Jorge Esparza-Gordillo, Ingo Marenholz, et al.
The Journal of Dermatological Treatment|May 21, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Thomas Bieber, Kenji Kabashima, et al.
Dermatology and Therapy|December 8, 2025
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b StudyAdam Reich, Andrew Blauvelt, Stephan Weidinger, et al.
Acta Dermato-Venereologica|April 26, 2021
Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitroMaxim A X Tollenaere, Thomas Litman, Lena Moebus, et al.
Dermatology and Therapy|March 17, 2022
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE StudyAndrew Alexis, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Pageof 28

Showing results (81-90 of 274) with videos related to

Sort By:
Pageof 28
Dermatology and Therapy|March 15, 2025
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED StudyStephan Weidinger, Tobias Schadeck, Felix Jacobs, et al.
The Journal of Investigative Dermatology|December 29, 2024
Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic ResponseRashmi Tandon, Inken Harder, Dora Stölzl, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2014
Skin barrier in atopic dermatitisSanja Kezic, Natalija Novak, Ivone Jakasa, et al.
Skin Pharmacology and Physiology|September 6, 2025
Effects of a gel containing the defined microalgae extract Spiralin® on the skin microbiome and clinical activity in atopic dermatitis - a double-blind, intraindividual vehicle-controlled proof-of-concept studyKristian Reich, Natalie Trettel, Jeremias L K Reich, et al.
Acta Dermato-Venereologica|June 11, 2015
Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and OmalizumabAlexander Zink, Anna Gensbaur, Michael Zirbs, et al.
BMC Medical Genetics|January 31, 2012
Multi-locus stepwise regression: a haplotype-based algorithm for finding genetic associations applied to atopic dermatitisSven Knüppel, Jorge Esparza-Gordillo, Ingo Marenholz, et al.
The Journal of Dermatological Treatment|May 21, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Thomas Bieber, Kenji Kabashima, et al.
Dermatology and Therapy|December 8, 2025
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b StudyAdam Reich, Andrew Blauvelt, Stephan Weidinger, et al.
Acta Dermato-Venereologica|April 26, 2021
Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitroMaxim A X Tollenaere, Thomas Litman, Lena Moebus, et al.
Dermatology and Therapy|March 17, 2022
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE StudyAndrew Alexis, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Pageof 28